Rebeca Dieguez-Gonzalez

Rebeca Dieguez-Gonzalez

Auto-generated profile, based on publicly available information

Rebeca Dieguez-Gonzalez

Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Stem Cell Reports
Verified
Journal Article
Open access
PRPauline Rimmelé
Pauline Rimmelé
CBCarolina L. Bigarella
Carolina L. Bigarella
RLRaymond Liang
Raymond Liang
BIBrigitte Izac
Brigitte Izac
RDRebeca Dieguez-Gonzalez
Rebeca Dieguez-Gonzalez
SGSaghi Ghaffari
Saghi Ghaffari
Aging hematopoietic stem cells (HSCs) exhibit defective lineage specification that is thought to be central to increased incidence of myeloid malignancies and compromised immune competence in the elderly. Mechanisms underlying these age-related defects remain largely unknown. We show that the deacetylase Sirtuin (SIRT)1 is required for homeostatic HSC maintenance. Differentiation of young SIRT1-deleted HSCs is skewed toward myeloid lineage associated with a significant decline in the lymphoid compartment, anemia, and altered expression of associated genes. Combined with HSC accumulation of damaged DNA and expression patterns of age-linked molecules, these have striking overlaps with aged HSCs. We further show that SIRT1 controls HSC homeostasis via the longevity transcription factor FOXO3. These findings suggest that SIRT1 is essential for HSC homeostasis and lineage specification. They also indicate that SIRT1 might contribute to delaying HSC aging.

12 September 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ACAlejo Chorny
Alejo Chorny
SCSandra Casas-Recasens
Sandra Casas-Recasens
JSJordi Sintes
Jordi Sintes
MSMeimei Shan
Meimei Shan
NPNadia Polentarutti
Nadia Polentarutti
ACAndrea Cerutti
Andrea Cerutti
Pentraxin 3 (PTX3) is a fluid-phase pattern recognition receptor of the humoral innate immune system with ancestral antibody-like properties but unknown antibody-inducing function. In this study, we found binding of PTX3 to splenic marginal zone (MZ) B cells, an innate-like subset of antibody-producing lymphocytes strategically positioned at the interface between the circulation and the adaptive immune system. PTX3 was released by a subset of neutrophils that surrounded the splenic MZ and expressed an immune activation–related gene signature distinct from that of circulating neutrophils. Binding of PTX3 promoted homeostatic production of IgM and class-switched IgG antibodies to microbial capsular polysaccharides, which decreased in PTX3-deficient mice and humans. In addition, PTX3 increased IgM and IgG production after infection with blood-borne encapsulated bacteria or immunization with bacterial carbohydrates. This immunogenic effect stemmed from the activation of MZ B cells through a neutrophil-regulated pathway that elicited class switching and plasmablast expansion via a combination of T cell–independent and T cell–dependent signals. Thus, PTX3 may bridge the humoral arms of the innate and adaptive immune systems by serving as an endogenous adjuvant for MZ B cells. This property could be harnessed to develop more effective vaccines against encapsulated pathogens.

25 April 2008 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
RDRebeca Dieguez‐Gonzalez
Rebeca Dieguez‐Gonzalez
MCManuel Calaza
Manuel Calaza
EPEva Perez-Pampin
Eva Perez-Pampin
ASArturo Rodriguez de la Serna
Arturo Rodriguez de la Serna
BFBenjamin Fernandez-Gutierrez
Benjamin Fernandez-Gutierrez
AGAntonio Gonzalez
Antonio Gonzalez
Objective: Previous studies have shown either a lack of effect of IRF5 polymorphisms or an association of the IRF5 gene in only a minor subset of rheumatoid arthritis (RA) patients in whom anti–citrullinated protein antibodies (ACPAs) are absent. The present study was undertaken to investigate the role of genetic variation in IRF5 in susceptibility to RA.Methods: Nine IRF5 single‐nucleotide polymorphisms (SNPs) were studied in 1,338 patients with RA and 1,342 control subjects in analyses of exploratory and replication sample collections, with stratification according to sex and by the presence or absence of ACPAs, rheumatoid factor, the shared epitope, the 620W PTPN22 allele, and erosions. A meta‐analysis that included results from previous studies was also carried out.Results: Our findings together with those from previous studies, in a total of 4,620 RA patients and 3,741 controls, showed a significant association of the rs2004640 IRF5 SNP in RA patients as a whole (odds ratio [OR] 0.88, 95% confidence interval [95% CI] 0.83–0.94; P = 6.5 × 10−5 versus controls). This association was stronger in ACPA− patients, but was also present in ACPA+ patients (from 3 sample collections). Further analysis of our exploratory sample collection showed that only patients in the ACPA+ and SE− group lacked an association with IRF5 SNPs. All of the remaining RA patients (ACPA− or SE+) showed a strong association with IRF5 SNPs, which followed a complex pattern of opposing effects mediated by independent haplotypes. The susceptibility haplotype showed an OR of 1.8 (95% CI 1.4–2.3; P = 1.2 × 10−6 versus controls), whereas the protective haplotype showed an OR of 0.76 (95% CI 0.6–0.98; P = 0.046 versus controls).Conclusion: IRF5 polymorphisms seem to influence RA susceptibility in a large subgroup of patients, following a pattern of association very similar to that described in patients with systemic lupus erythematosus.

17 September 2014 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
MMMaría José Moreno
María José Moreno
RBRosa Bosch
Rosa Bosch
RDRebeca Dieguez‐Gonzalez
Rebeca Dieguez‐Gonzalez
SNSilvana Novelli
Silvana Novelli
AMAna Mozos
Ana Mozos
ICIsolda Casanova
Isolda Casanova

27 August 2009 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
MSMarian Suarez‐Gestal
Marian Suarez‐Gestal
MCManuel Calaza
Manuel Calaza
RDRebeca Dieguez‐Gonzalez
Rebeca Dieguez‐Gonzalez
EPEva Perez-Pampin
Eva Perez-Pampin
JPJose Luis Pablos
Jose Luis Pablos
AGAntonio Gonzalez
Antonio Gonzalez
Objective: Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) share some genetic factors such as HLA, PTPN22, STAT4, and 6q23. The aim of this study was to determine whether 9 other SLE genetic factors are also implicated in RA susceptibility.Methods: A characteristic single‐nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13–BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain. The rs7574865 SNP in STAT4 was also included. Analyses were conducted globally and after stratification by sex and clinical features (anti–cyclic citrullinated peptide and rheumatoid factor, shared epitope, rheumatoid nodules, radiographic changes, sicca syndrome, and pneumonitis).Results: No association was observed between RA and any of the 9 newly identified SLE genetic factors. A meta‐analysis using previous data was consistent with these results. In addition, there were no significant differences between individuals with and those without each of the clinical features analyzed, except the frequency of the minor allele in the C8orf13–BLK locus that was decreased in patients with sicca syndrome (14.6% versus 22.4% in controls; P = 0.003).Conclusion: None of the 9 recently identified SLE risk factors showed association with RA. Therefore, common genetic factors affecting the pathogenesis of these 2 disorders seem to be limited, revealing that the genetic component contributes to the different expression of these diseases.

11 January 2014 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
LVLuis Vale
Luis Vale
RDRebeca Dieguez
Rebeca Dieguez
Laura SánchezLaura Sánchez
Laura Sánchez
Paulino MartinezPaulino Martinez
Paulino Martinez
AVAna Viñas
Ana Viñas